The People's Pharmacy

MAY 8, 2023

Why, then, are FDA inspections abroad so infrequent and disappointing? FDA Inspections Suspended: During the COVID pandemic, the Food and Drug Administration suspended its inspections at most foreign pharmaceutical facilities. Even under the best of conditions, the FDA never inspects all foreign pharmaceutical plants annually.

FDA 72

FDA Pharmaceutical Companies Pharmaceutical Companies Medical Schools 72

European Pharmaceutical Review

SEPTEMBER 25, 2023

Gregory’s industrial career spans an employment history with several major pharmaceutical companies. IPQ International Pharmaceutical Quality. 2007; 66(11-12): 963–8. 2007; 848(1): 79–87. 2007; 87(12): 2207–16. Cited 2023Feb]. Available from: [link] Egelhofer V, Gobom J, Seitz H, et al. Chromatographia.

Compounding 95

Compounding Pharmaceutical Companies Pharmaceutical Companies FDA 95

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Vaccines 113

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 113

PharmaShots

MARCH 29, 2023

Shots: Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years. The exact mechanism of action is uncertain.

FDA 49

FDA Chemotherapy Immunization Dosage 49

pharmaphorum

DECEMBER 21, 2021

However, despite the work still left to be done, there are now a growing number of treatments in the pipeline and 2020 proved to be a remarkable year for orphan drug approvals, with the US FDA approving more orphan designated treatments than non-orphan drugs.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies Hospitals FDA 95

pharmaphorum

JANUARY 16, 2023

There were developments in the past 12 months, true – Biogen/Eisai’s lecanemab (now branded Leqembi) showed clear success in the Clarity AD trial and received approval by FDA on 6th January 2023. Innovation will power the market. A new hope: new pharmacotherapeutic platforms become commercially viable.

FDA 90

FDA Pharmaceutical Companies Pharmaceutical Companies Compounding 90

Pharmaceutical Technology

AUGUST 17, 2008

Nicola Boyes: The FDA has come under criticism recently for extreme delays in approving new drugs for the market, is the criticism valid and if so how are the delays impacting on the US pharmaceutical industry at present? In terms of concerns over safety, it has meant that the FDA has been essentially very cautious in moving forward.

Labelling 52

Labelling FDA Pharmaceutical Companies Pharmaceutical Companies 52